FONAR Corporation
NASDAQ:FONRMedical - Devices
+$0.00 today
- Market cap
- $117.76M
- Beta
- 0.95
- P/E (TTM)
- 17.6
- EPS (TTM)
- $1.08
Volume 0.00M
Average 0.08M
FONR Other Non-Cash Items
Other non-cash adjustments that reconcile net income to operating cash flow.
FONAR CorporationNASDAQ: FONR
Other Non-Cash Items · Q3 FY2026 · quarter ended Mar 2026
Other non-cash items declines year over year
Q3 FY2026 other non-cash items of $213K fell 89.5% year over year, behind the -72.4% change in trailing-twelve-month other non-cash items. Over 3 fiscal years it compounded at +71.8% a year.
Context
- Other non-cash items amounted to 3.1% of revenue in FY2025, up 1.9 pp from a year earlier.
- Other non-cash items increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -89.5% toward the trailing-twelve-month pace of -72.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Non-Cash Items history
USD · from the cash flow
- Latest · FY2025
- 3.26M USD
- Year-over-year change
- +167.1%
- 4-year CAGR
- -18.9%
| Period | Period end | Other Non-Cash Items | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 3.26M | +167.1% |
| FY2024 | 2024-06-30 | 1.22M | -78.7% |
| FY2023 | 2023-06-30 | 5.73M | +790.9% |
| FY2022 | 2022-06-30 | 642.77K | -91.5% |
| FY2021 | 2021-06-30 | 7.53M | — |
Other Non-Cash Items vs competitors
How FONR compares with its peers on the latest reported figures
- Peers report in different currencies, so other non-cash items is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -72.4% is the lowest of 8, against a peer median of +166.7%.
- Other non-cash items amounts to 1.2% of revenue for FONR, versus a peer median of 6.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $16.27M USD | +832.9% | +9.9% | 18.4% | |
| LTM Mar 2026 | €6.04M EUR | +205.4% | — | 20599.5% | |
ARTVArtiva Biotherapeutics, Inc. | LTM Mar 2026 | $4.53M USD | +616.6% | — | — |
| LTM Mar 2026 | $3.34M USD | +84.6% | +25.7% | 4.6% | |
| LTM Mar 2026 | $2.83M USD | +118.8% | +48.1% | 5.1% | |
| LTM Mar 2026 | $1.28M USD | -72.4% | +71.8% | 1.2% | |
| LTM Mar 2026 | $958K USD | +166.7% | — | 6.2% | |
| LTM Mar 2026 | $125K USD | -60.3% | — | — | |
| Peer median (excluding FONR) | — | +166.7% | +25.7% | 6.2% | |
Competitors are the stored peer set for FONR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Net Income | 13.67M | 17.23M | 12.13M | 14.1M | 10.67M |
| Depreciation & Amortization | 5.54M | 8.54M | 8.8M | 4.6M | 4.7M |
| Deferred Income Tax | 3.53M | 3.09M | 2.98M | 2.8M | 823.66K |
| Stock-Based Compensation | 83.28K | 0 | 0 | 0 | 0 |
| Change in Working Capital | (11.26M) | (14.21M) | (15.17M) | (8.62M) | (8.19M) |
| Accounts Receivables | (11.91M) | (5.56M) | (8.12M) | (11.62M) | (8.98M) |
| Inventory | (14.65K) | (696.4K) | (209.85K) | (145.78K) | (97.24K) |
| Accounts Payables | (99.22K) | (314.77K) | 19.69K | 276.67K | (553.56K) |
| Other Working Capital | 762.59K | (7.64M) | (6.86M) | 2.87M | 1.44M |
| Other Non-Cash Items | 7.53M | 642.77K | 5.73M | 1.22M | 3.26M |
| Operating Cash Flow | 19.09M | 15.3M | 14.47M | 14.09M | 11.26M |
| Capital Expenditures | (4.82M) | (4.63M) | (4.34M) | (822.85K) | (3.82M) |
| Acquisitions (Net) | 0 | (546K) | 0 | 0 | 0 |
| Purchases of Investments | (293) | (149) | (473) | (103.3K) | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (163.71K) | (87.88K) | (119.57K) | 42.53K | (9.72K) |
| Investing Cash Flow | (4.82M) | (5.18M) | (4.34M) | (850.74K) | (3.8M) |
| Debt Repayment | (40.34K) | (37.24K) | (36.62K) | (44.9K) | (113.94K) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | (1.76M) | (2.51M) | (1.81M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (6.57M) | (5.82M) | (5.78M) | (5.63M) | (5.55M) |
| Financing Cash Flow | (6.61M) | (5.86M) | (7.57M) | (8.18M) | (7.47M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 7.66M | 4.26M | 2.56M | 5.06M | (7.56K) |
| Free Cash Flow | 14.27M | 10.67M | 10.13M | 13.27M | 7.45M |
FONAR Corporation
NASDAQ:FONR
Intrinsic Alpha fair value
Locked
Current Price
$19.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.